These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 23772077

  • 1. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y, Kondo H, Takeuchi T.
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [Abstract] [Full Text] [Related]

  • 2. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [Abstract] [Full Text] [Related]

  • 3. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M.
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN, Bergman MJ, Yourish J, Pei J, Reiss W, Keystone E.
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [Abstract] [Full Text] [Related]

  • 12. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
    Thiele K, Huscher D, Bischoff S, Späthling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A, German Collaborative Arthritis Centres.
    Ann Rheum Dis; 2013 Jul; 72(7):1194-9. PubMed ID: 22915625
    [Abstract] [Full Text] [Related]

  • 13. Assessing remission in clinical practice.
    Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS.
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [Abstract] [Full Text] [Related]

  • 14. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR, Shaver TS, Shahouri SH, Wang S, Anderson JD, Busch RE, Michaud K, Mikuls TR, Caplan L, Wolfe F.
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [Abstract] [Full Text] [Related]

  • 15. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S, Ozen G, Can M, Atagunduz P, Direskeneli H, Inanc N.
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS, Aletaha D.
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [Abstract] [Full Text] [Related]

  • 17. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME, Hsia E, Aletaha D.
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.